|
| 36179990 | External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 36889593 | Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. | Radiother Oncol | 2023 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 35588224 | ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. | Am J Clin Oncol | 2022 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 33897787 | Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants. | J Contemp Brachytherapy | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 34509378 | Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement. | Brachytherapy | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 34091475 | The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients. | Am J Clin Oncol | 2021 |
| 30992160 | Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. | Eur Urol | 2020 |
| 35474886 | The impact of age on prostate cancer progression and quality of life in active surveillance patients. | BJUI Compass | 2020 |
| 31740219 | The narrow door of success. | Brachytherapy | 2020 |
| 33102106 | CT-PLANNED transperineal prostate BIOPSY IN patients without a rectum. | Urol Case Rep | 2020 |
| 32628817 | Associations of multimorbidity and patient-reported experiences of care with conservative management among elderly patients with localized prostate cancer. | Cancer Med | 2020 |
| 32442822 | A biochemical definition of cure after brachytherapy for prostate cancer. | Radiother Oncol | 2020 |
| 32360452 | ACR Stakeholder Prostate Summit. | J Am Coll Radiol | 2020 |
| 31020423 | Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection. | World J Urol | 2020 |
| 30724780 | Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization. | Am J Clin Oncol | 2019 |
| 27906722 | Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy. | Am J Clin Oncol | 2018 |
| 29976500 | Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. | Int J Radiat Oncol Biol Phys | 2018 |
| 29509865 | Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. | JAMA | 2018 |
| 27740974 | Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone Levels. | Am J Clin Oncol | 2018 |
| 25068472 | Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance. | Am J Clin Oncol | 2017 |
| 28110898 | American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review. | Brachytherapy | 2017 |
| 28109632 | The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer. | Brachytherapy | 2017 |
| 29204160 | Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials. | J Contemp Brachytherapy | 2017 |
| 28951747 | Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA. | J Contemp Brachytherapy | 2017 |
| 27900453 | Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation. | World J Urol | 2017 |
| 27771243 | American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer. | Brachytherapy | 2017 |
| 25575041 | Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy. | Am J Clin Oncol | 2017 |
| 24517957 | Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy. | Am J Clin Oncol | 2016 |
| 26525214 | Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease? | Brachytherapy | 2016 |
| 27130262 | Pathology and Quality of Life Outcomes Following Office-based Transperineal Prostate Biopsy. | Urology | 2016 |
| 27053451 | Focal prostate brachytherapy with (103)Pd seeds. | Phys Med | 2016 |
| 23764680 | Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland. | Am J Clin Oncol | 2015 |
| 26489923 | Treatment outcomes with permanent brachytherapy in high-risk prostate cancer patients stratified into prognostic categories. | Brachytherapy | 2015 |
| 26816337 | Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts. | J Contemp Brachytherapy | 2015 |
| 26051802 | Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials. | Brachytherapy | 2015 |
| 25413425 | Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking. | Pract Radiat Oncol | 2015 |
| 25572299 | Severe rectal complications after prostate brachytherapy. | Radiother Oncol | 2015 |
| 24044872 | Multisector prostate dosimetric quality: analysis of a large community database. | Brachytherapy | 2014 |
| 25510812 | ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. | Oncology (Williston Park) | 2014 |
| 25337126 | Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy. | J Contemp Brachytherapy | 2014 |
| 25180754 | ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. | Am J Clin Oncol | 2014 |
| 24880587 | Response to Drs Rogers, Hayes, and Demanes. | Brachytherapy | 2014 |
| 24368283 | ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. | Brachytherapy | 2014 |
| 22307210 | Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance. | Am J Clin Oncol | 2013 |
| 24474970 | Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment. | J Contemp Brachytherapy | 2013 |
| 24143144 | Permanent prostate brachytherapy extracapsular radiation dose distributions: analysis of a multi-institutional database. | J Contemp Brachytherapy | 2013 |